Potential drug–drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria

References

• Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal AccessGenevaWorld Health Organization2006 Available from: http://www.who.int/hiv/pub/guidelines/paediatric020907.pdfAccessed October 22, 2011
   Google Scholar
• JordanRGoldLCumminsCHydeCSystematic review of meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapyBMJ200232475711923157
   PubMed Web of Science ®Google Scholar
• PirmohamedMDrug-drug interactions and adverse drug reactions: separating the wheat from the chaffWien Klin Wochenschr2010122626420213370
   PubMed Web of Science ®Google Scholar
• MillerCDEl-KholiRFaragonJJLodiseTPPrevalence and risk factors for clinically significant drug interactions with antiretroviral therapyPharmacotherapy2007271379138617896893
   PubMed Web of Science ®Google Scholar
• BaxterKStockley’s Drug Interactions9th edLondonPharmaceutical Press2010
   Google Scholar
• TatroDSDrug Interaction Facts. Facts and ComparisonsSt Louis, MOSt Louis Press2008
   Google Scholar
• YiuPNguyenNNHolodniyMClinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapyPharmacotherapy20113148048921923429
   PubMed Web of Science ®Google Scholar
• KigenGKimaiyoSNyandikoWUSAID-Academic Model for Prevention Treatment of HIV/AIDSPrevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohortPLoS One20106e1680021373194
   PubMed Web of Science ®Google Scholar
• BruceRDAlticeFCThree case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavirAIDS20062078378416514314
   PubMed Web of Science ®Google Scholar
• McCance-KatzEFMoodyDEMorseGDInteraction between buprenorphine and atazanavir or atazanavir/ritonavirDrug Alcohol Depend20079126927817643869
   PubMed Web of Science ®Google Scholar
• AlticeFCFriedlandGHCooneyELNevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadoneAIDS19991395796210371177
   PubMed Web of Science ®Google Scholar
• GermanPGreenhouseBCoatesCHepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenzClin Infect Dis20074488989117304470
   PubMed Web of Science ®Google Scholar
• UrielALewthwaitePMalaria therapy in HIV: drug interactions between nevirapine and quinineInt J STD AIDS20112276822174067
   PubMed Web of Science ®Google Scholar
• FrohoffCMoodleyMFairlieLAntiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatmentPLoS One20116
   Web of Science ®Google Scholar
• ZhangCMcIlleronHRenYPopulation pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected childrenAntivir Ther201217253322267466
   PubMed Web of Science ®Google Scholar
• GreenfieldRARiveraDMFryeREPediatric HIV infection treatment and management [webpage on the Internet]Medscape [updated September 3, 2013]. Available from: http://emedicine.medscape.com/article/965086-treatmentAccessed November 4, 2011
   Google Scholar
• YoungBReview: mixing new cocktails: drug interactions in antiretroviral regimensAIDS Patient Care STDS20051928629715916491
   PubMed Web of Science ®Google Scholar
• de MaatMMde BoerAKoksCHEvaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-careJ Clin Pharm Ther20042912113015068400
   PubMed Web of Science ®Google Scholar
• ShahSMcGowanJOpulskiBLiebleinASapersteinAIdentification of Drug Interactions Involving Antiretroviral Therapy (ART) in New York City HIV Specialty Clinics 2007 Available from: http://www.hiv-druginteractions.org/data/NewsItem/45_CROI%202007_1.pdfAccessed December 12, 2012
   Google Scholar
• MarzoliniCElziLGibbonsSSwiss HIV Cohort StudyPrevalence of comedications and impact of potential drug-drug interactions in the Swiss HIV Cohort StudyAntivir Ther20101541342320516560
   PubMed Web of Science ®Google Scholar
• Evans-JonesJGCottleLEBackDJRecognition of risk for clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapyClin Infect Dis2010501419142120380564
   PubMed Web of Science ®Google Scholar
• BrownBJOladokunREOdaiboGNOlaleyeDOOsinusiKKankiPClinical and immunological profile of pediatric HIV infection in Ibadan, NigeriaJ Int Assoc Physicians AIDS Care (Chic)201110495321368015
   PubMedGoogle Scholar
• WHO Multicentre Growth Reference Study GroupWHO Child Growth Standards based on length/height, weight and ageActa Paediatr Suppl2006450768516817681
   PubMedGoogle Scholar
• National Guidelines for Paediatric HIV and AIDS Treatment and CareFederal Ministry OF Health Nigeria2007 Available from: http://www.who.int/hiv/amds/Nigeria_paediatric_2007.pdfAccessed November 30, 2011
   Google Scholar
• Liverpool HIV Pharmacology Group (LHPG) Available from: http://www.hiv-druginteractions.org/main.aspx?PageId=7Accessed December 1, 2011
   Google Scholar
• GuyattGHOxmanADVistGEGRADE Working GroupGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ200833692492618436948
   PubMed Web of Science ®Google Scholar
• ArmahizerMKane-GillSLSmithburgerPLAnthesAMSeybertALComparing drug-drug interaction severity for clinician opinion to proprietary databasesAdv Pharmacoepidemiol Drug Saf20121115
   Google Scholar
• Database of antiretroviral drug interactions [database on the Internet]San Francisco, CAUniversity of California San Francisco Available from: http://hivinsite.ucsf.edu/InSite?page=ar-00-02Accessed February 25, 2013
   Google Scholar
• Review: prednisone and nevirapine [webpage on the Internet]eHealthMe2013 Available from: http://www.ehealthme.com/drug-interactions/prednisone-and-nevirapineAccessed June 2, 2013
   Google Scholar
• PieperBSmithermanHCJrAltered bleeding time associated with ibuprofen and zidovudine useNurse Pract199823747580839614682
   PubMedGoogle Scholar
• LeapeLLBatesDWCullenDJSystems analysis of adverse drug events. ADE Prevention Study GroupJAMA199527435437791256
   PubMed Web of Science ®Google Scholar
• WongCMKoYChanAClinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendiaAnn Pharmacother2008421737174819033481
   PubMed Web of Science ®Google Scholar
• Federal Republic of NigeriaNational Antimalarial Treatment PolicyAbujaFederal Ministry of Health, National Malaria and Vector Control Division2005 Available from: http://apps.who.int/medicinedocs/documents/s18401en/s18401en.pdfAccessed October 12, 2012
   Google Scholar
• EdeluBOIkefunaANEmodiJIAdimoraGNAwareness and use of insecticide-treated bed nets among children attending outpatient clinic at UNTH, Enugu – the need for an effective mobilization processAfr Health Sci20101011711921326961
   PubMed Web of Science ®Google Scholar
• Infection and travel in patients with HIV disease: malaria prophylaxis [webpage on the Internet]San Francisco, CAUniversity of California San Francisco Available from: http://hivinsite.ucsf.edu/InSite?page=kb-03-01-09#S3.5XAccessed February 25, 2013
   Google Scholar
• KhooSBackDWinstanleyPThe potential for interactions between antimalarial and antiretroviral drugsAIDS200519995100515958830
   PubMed Web of Science ®Google Scholar
• GermanPParikhSLawrenceJLopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteersJ Acquir Immune Defic Syndr20095142442919506482
   PubMed Web of Science ®Google Scholar
• KredoTMauffKVan der WaltJSInteraction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patientsAntimicrob Agents Chemother2011555616562321947399
   PubMed Web of Science ®Google Scholar
• WakehamKParkes-RatanshiRWatsonVGgayiABKhooSLallooDGCo-administration of fluconazole increases nevirapine concentrations in HIV-infected UgandansJ Antimicrob Chemother20106531631920032007
   PubMed Web of Science ®Google Scholar
• BrockmeyerNHTillmannIMertinsLBarthelBGoosMPharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patientsEur J Med Res199723773839300934
   PubMedGoogle Scholar
• ViolariALindseyJCHughesMDNevirapine versus ritonavir-boosted lopinavir for HIV-infected childrenN Engl J Med20123662380238922716976
   PubMed Web of Science ®Google Scholar
• RobinsonPGigliottiMLamsonMAzzamSMacgregorTEffect of reverse transcriptase inhibitor, nevirapine, on the steady-state pharmacokinetics of clarithromycin in HIV-positive patients [abstract #374]6th Conference on Retroviruses and Opportunistic InfectionsJanuary 30–February 2, 1999Chicago, IL Available from: http://retroconference.org/1999/abstracts/374.htmAccessed January 7, 2013
   Google Scholar
• PolisMAPiscitelliSCVogelSClarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionAntimicrob Agents Chemother199741170917149257746
   PubMed Web of Science ®Google Scholar
• SmithburgerPLKane-GillSLBenedictNJFalcioneBASeybertALGrading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankingsAnn Pharmacother2010441718172420959499
   PubMed Web of Science ®Google Scholar
• FTC (emtricitabine, Emtriva) [webpage on the Internet]LondonNAM Publications Available from: http://www.aidsmap.com/resources/treatmentsdirectory/drugs/FTC-emtricitabine-iEmtrivai/page/1731063/Accessed February 24, 2013
   Google Scholar